Showing results (101-110 of 259) with videos related to
Sort By:
Pageof 26
Clinical Pharmacology and Therapeutics|November 1, 1979
Effect of probenecid on cerebrospinal fluid methotrexate kineticsS B Howell, R A Olshen, J A RiceCancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B HowellJournal of the National Cancer Institute|January 1, 1981
Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cellsB C Chu, C C Fan, S B HowellCancer Drug Delivery|January 1, 1986
The effect of amitriptyline on the central nervous system penetration of methotrexateR L Heideman, F M Balis, S Zimm, et al.Cancer Treatment Reports|February 1, 1984
Modulation of cytarabine uptake and toxicity by dipyridamoleM E King, A Naporn, B Young, et al.Somatic Cell and Molecular Genetics|March 4, 2000
Chromosomal localization and genomic structure of the human arsenite-stimulated ATPase (hASNA-I)B Kurdi-Haidar, D Heath, G Lennon, et al.The Journal of Infectious Diseases|September 1, 1990
Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomesS Kim, S Scheerer, M A Geyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell lineE Kimura, R E Enns, F Thiebaut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavityM Markman, S Cleary, W E Lucas, et al.Cancer|November 15, 1985
High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicityM Markman, S Cleary, C E Pfeifle, et al.Pageof 26